General Archive
-
News releases
New drug discovery collaborations with Queen Mary University of London launched
The first collaboration will develop selective formyl peptide receptor 2 (FPR2) agonists for the treatment of ischaemia reperfusion injury. The…
-
News releases
MRCT announce second drug discovery collaboration with University of Bristol
This project will focus on developing novel modulators of the second galanin receptor subtype (GalR2) for neuropathic pain, a major…
-
News releases
Mount Sinai School of Medicine and MRC Technology to collaborate on monoclonal antibody production and humanization
The collaboration will focus on the development of monoclonal antibodies that can be commercialized as drugs to control infection and…
-
News releases
MRC Technology launches research grant terms approval service
The newly-launched research grant terms approval service, provided the MS Society with the first review. As an expert in commercialising…
-
News releases
Phosphate Therapeutics acquires novel phosphate binder (PT20) from the Medical Research Council and secures development funding from Inventages venture capital for compound’s phase 2 development
Phosphate Therapeutics has acquired the global rights to PT20, a novel Phase 2 ready phosphate binder for the treatment of…
-
News releases
New drug discovery collaboration with University of Bristol launched
Collaboration aims to develop orally available small molecule TrkA antagonists for treatment of chronic intractable pain.
-
News releases
New cancer therapeutic antibody project launched
MRC Technology’s Therapeutic Antibody Group and The University of Aberdeen will work together on a project to develop a therapeutic…
-
News releases
Aptuscan acquired by Avacta
Aptuscan, a spin out company based on research carried out by Paul Ko Ferrigno whilst working at the MRC Cancer…
-
News releases
MRC Technology to manage intellectual property for AICR
This is the first such agreement signed by MRC Technology, delivering on a new strategy to broaden its service to…
-
News releases
MRC scientists redefine how our immune system responds to viruses
Landmark research from the Medical Research Council (MRC) has discovered that antibodies can fight viruses from within infected cells. This…
-
News releases
Scientists ‘give botox a facelift’ to improve use for Parkinson’s
Researchers funded by the Medical Research Council (MRC) have developed a new method of joining and rebuilding molecules in the…
-
News releases
1st patient treated with BAN2401
BAN2401, the antibody by MRC Technology humanized for Swedish biopharmaceutical company BioArctic Neuroscience AB (Stockholm), has entered clinical trials to…